Executive Search Success Story: Building Global Leadership for a Cardiovascular Implantable Device Company

How JRG Partners executed a highly confidential, multi-role international executive search strategy that equipped a leading cardiovascular implantable device company with the global commercial, market-access, and quality leadership infrastructure required to accelerate international expansion and scale next-generation structural heart and cardiac rhythm management technologies.

The Challenge

A leading cardiovascular implantable device company was preparing for significant growth following the development of several next-generation technologies targeting structural heart and cardiac rhythm management markets. Although the company possessed strong underlying innovation capabilities, leadership identified several pressing organizational and geographic challenges that threatened their international expansion velocity:

• Limited executive bench strength to support rapid cross-border expansion
• Increasing competition for highly specialized cardiovascular and implantable device talent
• Complex global commercialization and go-to-market requirements
• The challenge of scaling clinical operations and specialized physician-training programs
• Growing international reimbursement differences and market-access complexities
• A baseline shortage of experienced executives capable of leading international growth initiatives
• Succession concerns and retirement risks within key leadership positions

The Board and executive leadership team determined that strategic, synchronized hiring would be necessary to support future growth objectives. The confidential mandate covered a Chief Operating Officer, VP Global Commercial Operations, VP Market Access, VP Clinical Education, VP Quality Assurance, Director of International Sales, and Global Business Development executives. The company required a search partner with deep sector expertise and direct access to leaders capable of scaling global operations.

Why They Chose JRG Partners

Deep Cardiovascular Device Industry Expertise

JRG Partners specializes explicitly in recruiting executives across cardiovascular devices, implantable technologies, structural heart solutions, electrophysiology products, and global healthcare organizations. Our consultants possess an intimate operational understanding of international commercialization, physician-adoption strategies, and complex global healthcare markets.

Access to Passive Executive Talent

Many of the most successful cardiovascular device executives are fully employed at top-tier organizations and are not actively seeking new opportunities through standard recruiting channels. JRG Partners leveraged proprietary research methods, targeted intelligence, and extensive personal industry relationships to identify highly qualified leaders unavailable on the open market.

Confidential Search Execution

Several of the executive searches involved replacing retiring leaders while maintaining sensitive operational continuity and protecting internal organizational stability. JRG Partners conducted these recruitment assignments with absolute discretion throughout the entire lifecycle.

True International Reach

Sourcing elite global leadership required a borderless approach. JRG Partners successfully mapped and engaged top-tier executive talent throughout the primary medical device corridors of both North America and Europe.

Our Executive Search Strategy

Phase 1 — Leadership & Global Assessment

Our consultants partnered directly with executive leadership to deeply assess international-growth objectives, leadership-succession risks, commercial-expansion priorities, regional market-access requirements, clinical-education initiatives, quality compliance needs, and cultural objectives. Rather than recruiting against generic job descriptions, we developed specific executive profiles aligned with the company’s five-year growth strategy.

Phase 2 — Cardiovascular Talent Mapping

JRG Partners conducted a comprehensive global market-mapping initiative covering structural heart device manufacturers, cardiac rhythm management companies, electrophysiology organizations, global medical device firms, healthcare technology businesses, and emerging cardiovascular innovators. More than 500 executive profiles were systematically identified and evaluated.

Phase 3 — Targeted Executive Engagement

Using a research-driven, discreet outreach framework, our consultants engaged leaders with a demonstrated history of success in global commercialization, physician-training programs, international market expansion, market-access strategy, clinical-operations leadership, business-development initiatives, and quality management. Only candidates demonstrating measurable business impact and leadership excellence advanced.

Phase 4 — Rigorous Evaluation & Selection

Each finalist underwent an extensive, data-validated evaluation covering strategic leadership capability, global business experience, commercial-growth success, team-building effectiveness, quality and regulatory expertise, cultural alignment, and long-term retention potential.

Key Outcomes

• 500+ targeted structural heart, CRM, and global medical device executive profiles mapped across North American and European innovation hubs.
• Successfully placed and integrated a synchronized, seven-member leadership infrastructure spanning global operations, international sales, and clinical education within 14 months.
• Accelerated market penetration and entry timelines into competitive European and North American territories via newly placed international sales and commercial operations leaders.
• Optimized cross-border product adoption by introducing highly specialized market-access executives fluent in complex regional reimbursement and payer frameworks.
• Upgraded global product delivery and compliance pipelines under incoming quality assurance leadership, mitigating international regulatory risks.
• Protected organizational stability and maintained factory floor and R&D continuity during sensitive retirement transitions through confidential search protocols.
• Provided the Board of Directors and institutional investors with a resilient, scalable corporate infrastructure aligned to monetize next-generation cardiovascular technologies globally.